Pfizer is one of the most dynamic and profitable companies in the world. With sales of over $52 billion and 17% growth in 2003/04, it leads the pharmaceutical market and has influenced the way the market is shaped. Pfizer currently has 145 products in the pipeline at least in Phase I clinical trials and has [...]
Filed under: 2005-2010, Pfizer - Current Difficulties and Future Challenges | No Comments »
